Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001505512-14-000001
Filing Date
2014-02-06
Accepted
2014-02-06 15:28:57
Documents
1
Effectiveness Date
2014-02-06
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11996
  Complete submission text file 0001505512-14-000001.txt   13141
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-211442 | Film No.: 14579865
SIC: 2834 Pharmaceutical Preparations